What is the 13F Pro Quality Score for TNON?

13F Pro ranks Tenon Medical, Inc. (TNON) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View TNON's current score at https://13fpro.ai/company/TNON (free sign-up required for the full ranking).

Where does 13F Pro source TNON data?

All Tenon Medical, Inc. fundamentals and ownership data come directly from SEC EDGAR. Tenon Medical, Inc. files with the SEC under CIK 1560293. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is TNON in?

Tenon Medical, Inc. (TNON) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

How often is TNON research updated on 13F Pro?

TNON's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

Tenon Medical, Inc.(TNON)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →Nasdaqsmall

Institutional-grade research for retail investors

SEC EDGAR: CIK 1560293 TNON stock profile & AI dashboard →

13F Pro Quality Score

29.4/100

Rank #2,530 of 2,962 stocks

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Email me the moment this company reports earnings

AI Research Report

Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.

Upgrade to Pro

Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

Why TNON Scores 29/100

exact factor attribution · 2026-09-11

TNON's composite is driven by revenue growth and institutional flow, held back by scale and free cash flow. Bars show each factor's exact push vs. a median company, using the same weights the ranking engine applies.

Revenue growth

+6.9 pts

84th pct

Institutional flow

+2.5 pts

100th pct

Earnings growth

-1.5 pts

20th pct

Shareholder dilution

-2.1 pts

9th pct

Earnings quality

-2.8 pts

22th pct

Capital efficiency

-4.7 pts

3th pct

Profitability

-6.0 pts

10th pct

Free cash flow

-6.2 pts

9th pct

Scale

-6.7 pts

6th pct

Factor percentiles are cross-sectional ranks across the ~2,800-stock scored universe, computed from SEC EDGAR filings. Not investment advice.

TNON Stock Analysis & AI Quality Score

Data updated 2026-09-11

AI stock analysis and institutional research for Tenon Medical, Inc. (TNON), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores TNON at 29.4/100 on a 32-signal composite quality model, placing it at rank #2,530 of 2,962 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (Q2 2026), Tenon Medical, Inc. reports quarterly revenue of $1.3M, net income of $-4.0M, free cash flow of $-2.9M. Top institutional holders of TNON by reported 13-F value include Warberg Asset Management, ARMISTICE CAPITAL, Focus Partners Wealth, based on the most recent SEC filings. TNON trades on the Nasdaq exchange and files with the SEC under CIK 1560293. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate TNON daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Tenon Medical, Inc. directly from SEC EDGAR. Tenon Medical, Inc.'s 13F Pro composite quality score has ranged between 28 and 31 since 2026, currently 29.4 — a stable long-term trajectory across 8 quarterly and live scoring snapshots.

Revenue

Q2 2026

$1.3M

Net Income

Q2 2026

$-4.0M

Free Cash Flow

Q2 2026

$-2.9M

Period

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro

Revenue

+20.4% YoY

$3.9MFY 2025

FY22 $691.0KFY23 $2.9MFY24 $3.3MFY25 $3.9M

Net Income

+8.2% YoY

$-12.6MFY 2025

FY22 $-18.9MFY23 $-15.6MFY24 $-13.7MFY25 $-12.6M

Operating Income

+7.1% YoY

$-12.8MFY 2025

FY22 $-18.7MFY23 $-15.7MFY24 $-13.8MFY25 $-12.8M

EPS (Diluted)

+84.9% YoY

$-1.70FY 2025

FY22 $-23.62FY23 $-68.64FY24 $-11.26FY25 $-1.70

Total Assets

+9.3% YoY

$10.8MFY 2025

FY22 $11.1MFY23 $6.3MFY24 $9.8MFY25 $10.8M

Op. Cash Flow

-8.8% YoY

$-10.7MFY 2025

FY22 $-12.0MFY23 $-12.2MFY24 $-9.9MFY25 $-10.7M

Free Cash Flow

-9.5% YoY

$-11.0MFY 2025

FY22 $-12.9MFY23 $-12.5MFY24 $-10.1MFY25 $-11.0M

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Revenue	$3.9M +20.4%	$3.3M +11.9%	$2.9M +323.7%	$691.0K +331.9%	$160.0K	—
Net Income	$-12.6M +8.2%	$-13.7M +12.2%	$-15.6M +17.6%	$-18.9M -168.4%	$-7.0M	—
Operating Income	$-12.8M +7.1%	$-13.8M +12.5%	$-15.7M +16.0%	$-18.7M -189.8%	$-6.5M	—
EPS (Diluted)	$-1.70 +84.9%	$-11.26 +83.6%	$-68.64 -190.6%	$-23.62 -202.4%	$-7.81	—
Total Assets	$10.8M +9.3%	$9.8M +55.1%	$6.3M -42.8%	$11.1M +19.6%	$9.3M	—
Operating Cash Flow	$-10.7M -8.8%	$-9.9M +18.9%	$-12.2M -1.3%	$-12.0M -180.2%	$-4.3M	—
Free Cash Flow	$-11.0M -9.5%	$-10.1M +19.8%	$-12.5M +2.5%	$-12.9M -192.9%	$-4.4M	—

Get alerted when TNON's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for Tenon Medical, Inc. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of TNON

Warberg Asset Management LLC
$140.4K430,407 sh
ARMISTICE CAPITAL, LLC
$56.2K172,105 sh
Focus Partners Wealth
$51.0K4,720,000 sh
HRT FINANCIAL LP
$27.0K84,605 sh
GEODE CAPITAL MANAGEMENT, LLC
$26.3K80,566 sh
VANGUARD CAPITAL MANAGEMENT LLC
$23.4K71,715 sh
VANGUARD FIDUCIARY TRUST CO
$14.5K44,628 sh
SBI Securities Co., Ltd.
$13.0K39,725 sh
Clear Street Group Inc.
$10.3K952,794 sh
NORTHERN TRUST CORP
$10.1K31,043 sh

Fund	Value	Shares
Warberg Asset Management LLC	$140.4K	430,407
ARMISTICE CAPITAL, LLC	$56.2K	172,105
Focus Partners Wealth	$51.0K	4,720,000
HRT FINANCIAL LP	$27.0K	84,605
GEODE CAPITAL MANAGEMENT, LLC	$26.3K	80,566
VANGUARD CAPITAL MANAGEMENT LLC	$23.4K	71,715
VANGUARD FIDUCIARY TRUST CO	$14.5K	44,628
SBI Securities Co., Ltd.	$13.0K	39,725
Clear Street Group Inc.	$10.3K	952,794
NORTHERN TRUST CORP	$10.1K	31,043

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put TNON on your watchlist

Track score changes the day Tenon Medical, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is TNON a good stock to buy?

13F Pro's AI-powered analysis of Tenon Medical, Inc. (TNON) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for TNON are available on the TNON stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. TNON is classified as a small company.

Which hedge funds own TNON?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling TNON. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Tenon Medical, Inc.'s investment landscape.